Post by Solvias

‼️Nearly 1 in 5 FDA Complete Response Letters published this year cite E&L-related deficiencies. What can developers learn from these setbacks and how can you avoid them? In our latest white paper, we break down the most common pitfalls and share strategies to design robust, risk-based E&L studies that accelerate approval timelines and strengthen regulatory confidence. 📄 Download the white paper here: https://lnkd.in/eAkuyg7b #ExtractablesAndLeachables #E&L #extractables #leachables #CRL